Hope Abounds Cancer Network’s Post

Looking for more ways to deal with the challenges that come with advanced cancer? Find resources, information, support, and hope at www.sayyestohope.org. #SayYEStoHope #AdvancedCancer #BeeTheChange #changetheworldofadvancedcancer #TreatmentOptions #researchsaveslives #YouAreYourOwnBestAdvocate #teamwork #multidisciplinarytreatmentteam

The Future of Endometrial Cancer Screening: CISENDO® and DNA Methylation Analysis Endometrial cancer is the most common gynecological malignancy. Early detection is crucial for improving patient outcomes. CISENDO® highlights the exciting potential of DNA methylation analysis, particularly of the CDO1 and CELF4 genes, for non-invasive screening and detection of endometrial cancer and precancerous lesions. **Key Findings and Implications:** * **Non-invasive Diagnosis:** This approach offers a promising alternative to traditional biopsies, using cervical exfoliated cells for analysis. * **High Accuracy:** Methylation testing of CDO1 and CELF4 demonstrates strong potential for accurate detection, especially when combined with existing methods like TVUS and CA125. * **Risk Stratification:** Identifying high-risk patients (e.g., postmenopausal women with abnormal bleeding) allows for prioritized evaluation and potentially avoids unnecessary procedures. * **Regional Specificity:** DNA methylation patterns may pinpoint specific areas of concern in the uterine cavity, reducing the need for invasive tissue sampling. * **Broad Applicability:** Analysis works across ethnicities, highlighting its value for widespread use.  * **Personalized Medicine:** Combined with molecular subtyping, methylation analysis can offer valuable insights for disease classification, prognosis, and treatment tailoring. **Overall, DNA methylation analysis holds immense promise for the early detection and management of endometrial cancer, potentially improving patient outcomes and reducing unnecessary procedures.** #endometrialcancer #DNAmethylation #CISENDO #womenshealth #earlydetection #personalizedmedicine **Let's discuss the future of endometrial cancer screening in the comments!**

Dive into the latest episode of Myths "O" Facts Series with Dr. Sandeep Nayak as he addresses a common concern "PET CT can diagnose cancer" 🤔 Stay informed and join the conversation on debunking myths surrounding cancer. Watch Here: https://lnkd.in/grUBX_iw #DrSandeepNayak #macsclinic #samrohana #CancerAwareness #MythsOFacts #SurvivorStories #MedicalMyths #OncologyInsights #HealthEducation #InspireHope #MythBusting #CancerResilience #EmpowermentSeries #PositiveMindset #InspirationalHealth #BreakTheStigma #OvercomingChallenges #MedicalFacts #PatientAdvocacy #LivingWithCancer #HopeAfterCancer #CancerJourney #SupportiveCare #WellnessEducation #HealthEmpowerment #HealingJourneys #FightAgainstCancer

One hospital's journey in optimizing cancer testing shows how collaboration is key to providing the right test at the right time for each patient. https://ow.ly/FlgI50R4Tr6

According to the National Cancer Institute, cancer is one of the most expensive conditions to treat, but there are avenues for assistance. Learn more about these five organizations that can help you manage treatment-related expenses 👉 https://lnkd.in/eE9WcTpQ #HealthInsurance #FinancialAssistance #DigitalHealthStartup #OncologySupport

WHAT’S IN A NAME: How Advances in Identifying Cancer Can Impact Treatment Our blog's feature article today takes a closer look at how tumor classification has evolved and what that has meant for our vet’s ability to treat cancer successfully. Head on over to our website to read more, and please share this with your friends and followers. https://lnkd.in/gAWrDB8s #share #petcancerawareness #pethealth #petwellness #earlyintervention #doglover #doglife #doglovers #catlife #catlovers

#CICON2024 highlighted key developments in cancer #immunotherapy, a running theme was the incredible importance of new technologies for data analysis. Read more in this conference roundup from Cassie Houtz >>> https://hubs.ly/Q02Qdv7c0

Discover the future of cancer detection and monitoring! 🩸✨ I just published an in-depth article on 'What is a Liquid Biopsy? A New Way to Find and Track Cancer.' Click the link below to read the full article and learn how this revolutionary method is changing cancer care. https://lnkd.in/dUAhFP2U follow Smartcare Diagnostics Pvt Ltd for more such articles and updates #smartcare #smartcarelab #healthcare #smarthealth #smartcarediagnosticspvtltd #heal #CancerDetection #LiquidBiopsy #HealthInnovation

Excellent post about overdiagnosis, one of the hidden risks of cancer screening, from my colleague Dr. Sarah Coles at Those Nerdy Girls. This is NOT the same thing as a false positive, which is when you get told you may have cancer, but further testing reveals that you don't. Overdiagnosis is when we find a real tumour (cancer), but this tumour wouldn't have caused problems if we left it alone. Unfortunately, doctors can't perfectly predict which tumours can be safely left untreated, so we tend to treat them all. Thus, overdiagnosis leads to overtreatment. We know that overdiagnosis is a major issue for many cancers (especially prostate and breast) when cancer screening programs save modest numbers of lives despite detecting many more early-stage cancers. This doesn't mean we shouldn't get screened, but it does mean that the cost-benefit of screening isn't as simple as it may appear (not every cancer "caught" is a win). It also means that we need to keep investing in early detection research so that we can identify which cases need treatment and which can be safely left alone. #earlydetection #cancerearlydetection #cancerscreening #cancerresearch

Want to help advance cancer research? Fewer teens with cancer are involved in clinical trials, and this could be affecting how quickly we find better treatments for young people. The good news? Researchers are looking at ways to make trials more accessible for everyone. Check out this study to learn more about the challenges and what we can do to break down barriers! https://lnkd.in/grMyxdzJ #TAPintoCancerControl #gwccTAP #CancerResearch #ClinicalResearch #ClinicalTrials